Antipsychotic Current Events | Antipsychotic News | 3
|
|
|
Sort By:
Page Views | Date |
Brain imaging studies show attention to thinking in schizophrenia improves outlook for patients
A focus on schizophrenia as 'a disorder of thinking' promises much for patients with the condition, according to Dr Tonmoy Sharma, Head of the Section of Cognitive Psychopharmacology (SCP) at the Institute of Psychiatry. In a presentation to journalists during Brain Awareness Week, Dr Sharma outlined new research showing the importance of... view more... (1999-03-16)
Flow of potassium into cells implicated in schizophrenia
A study on schizophrenia has implicated machinery that maintains the flow of potassium in cells and revealed a potential molecular target for new treatments. view more (2009-05-06)
First generation antipsychotic drugs as effective as newer ones in some children
Nearly every child who receives an antipsychotic medicine is first prescribed one of the second-generation, or "atypical" drugs, such as olanzapine and risperidone. However, there has never been evidence that these drugs are more effective than the older, first-generation medications. view more (2008-09-15)
Scientists throw light on drug-induced weight gain
Researchers at the University of Sheffield have identified two genes that could prevent millions of patients from gaining weight as a result of their medication. Their work is being presented at the American Psychiatric Association's annual meeting in San Francisco on Tuesday May 20th. view more (2003-05-15)
Early and network-oriented care may help adolescents at risk of developing psychosis
Family and network oriented, stress-reducing care improves level of overall functioning and mental health in adolescents at risk of developing psychosis, suggests a recent Finnish study. view more (2009-05-15)
Schizophrenia could cause patients to forget their medication
Patients with schizophrenia must take medication regularly to reduce their risk of relapse. But the disease impairs memory, according to an article published in BMC Psychiatry, meaning these patients may have difficulty in remembering to take their tablets. Habitual tasks, like taking medicine every few hours, rely on "prospective... view more... (2003-08-12)
Study raises new treatment possibilities for cognitive disorders
UC Irvine researchers have identified a new class of compounds that could be used for drugs to treat cognitive disorders that accompany schizophrenia, Alzheimer's disease and ADHD. view more (2007-05-02)
Lack of motivation in schizophrenia linked to brain chemical imbalance
A study of patients with psychotic illnesses such as schizophrenia suggests an alternative explanation for why many sufferers lack motivation. The research is described today BioMed Central's journal BMC Psychiatry. view more (2008-05-08)
Glutamate: Too much of a good thing in schizophrenia?
Is schizophrenia a disorder of glutamate hyperactivity or hypoactivity? While the predominant hypothesis for many years was that schizophrenia was a glutamate deficit disorder, there is growing evidence of glutamate hyperactivity as well. view more (2008-10-28)
Cost control measures limit patient and physician choice in psychotropic medications
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. view more (2007-03-02)
Hopkins researchers discover new link to schizophrenia
Neuroscientists at Johns Hopkins have discovered that mice lacking an enzyme that contributes to Alzheimer disease exhibit a number of schizophrenia-like behaviors. view more (2008-05-09)
Researchers discover link between schizophrenia and diabetes
People with schizophrenia are at increased risk for type 2 diabetes, Medical College of Georgia researchers have found. view more (2009-03-31)
Studies suggest new brain protein may help in treating schizophrenia, insomnia and anxiety
A small protein in the brain that has only recently been discovered and, paradoxically, induces both profound wakefulness and a less anxious state, may represent a novel target for the treatment of psychotic behavior and schizophrenia. view more (2006-06-23)
UI Study Reveals Value of Schizophrenia-Related Gene Variation
University of Iowa researchers have learned more about a genetic variation that is a small risk factor for a mild form of schizophrenia, yet also is associated with improved overall survival. view more (2007-02-14)
Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
The number of visits to a doctor's office that resulted in a diagnosis of bipolar disorder in children and adolescents has increased by 40 times over the last decade, reported researchers funded in part by the National Institutes of Health (NIH). view more (2007-09-04)
Bipolar spectrum disorder may be underrecognized and improperly treated
A new study supports earlier estimates of the prevalence of bipolar disorder in the U.S. population, and suggests the illness may be more accurately characterized as a spectrum disorder. view more (2007-05-08)
Efficacy and safety of Aripiprazole as adjunctive therapy in major depressive disorder
In adults with major depressive disorder, adding aripiprazole to antidepressant therapy (ADT) resulted in significant improvement in the primary endpoint, the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score. view more (2007-05-22)
Antipsychotic drug controls some symptoms in autism disorder
Risperidone, a drug used to control schizophrenia symptoms, may also help treat behaviors found in autism spectrum disorder, according to a new review of studies. view more (2007-01-31)
|
|
|
|
Sort By:
Page Views | Date |
|
